Live from ACCC

At the recent ACCC Business Summit, Carevive made a significant impression with their session on engaging patients and evaluating clinical cancer programs. Rebekkah Schear and Robin Richardson from UT Austin Dell Medical School Cancer Institute shared their takeaways and the positive reception they received during and after the session.

Engaging Patients and Evaluating Clinical Cancer Programs:

Carevive’s methods of engaging patients and educating them on important aspects of their care resonated with the audience. The session highlighted the need for comprehensive evaluation of clinical cancer programs, going beyond traditional metrics like survival and ED visits. Attendees were eager to learn more about measuring quality of life, patient experience, and provider experience. Carevive’s chart abstraction tool emerged as a valuable resource for capturing and analyzing data.

Interest in Data Sources and Tools:

Attendees were particularly interested in the sources of data used in evaluations and the tools employed to capture it. Carevive’s emphasis on data-driven process improvement and better outcomes struck a chord with the audience. Many expressed curiosity about the tools Carevive developed and their effectiveness.

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…